Early Intervention in Psychiatry · 2023 · 11 citations · 26 references
MedicineNeurosciencePsychiatryClinical NeuroscienceNeuropsychiatryPsychiatric AssessmentCerebrospinal Fluid BiomarkersNeurodevelopmental DisordersNeuropsychological AssessmentPsychiatric DiagnosisSchizophrenia Spectrum DisordersBiomarkersNegative Symptoms AssessmentNeurobiological MarkersP75 Neurotrophin ReceptorPlasma Protein BiomarkersPsychotic Symptom RatingS100b ProteinSchizophrenia Spectrum Symptom Assessment
Abstract Aim Schizophrenia onset in the developmental age has a strong neurodevelopmental burden and is associated with a poorer prognosis. The approach to diagnosis is still based on symptomatic description without objective validation. In this study, we aimed to compare the peripheral blood levels of hypothesized biomarker proteins: brain‐derived neurotrophic factor (BDNF), proBDNF, p75 neurotrophin receptor (p75 NTR ) and S100B between early‐onset schizophrenia‐spectrum adolescents ( n = 45) and healthy controls ( n = 34). Methods Clinical assessment of the participants encompassed symptomatic description with the use of structured interviews and executive function objective measurement. Plasma levels of BDNF protein were significantly lower in schizophrenia patients than in controls both at admission ( p = .003) and 6–8 weeks follow‐up ( p = .007). Results We observed significant correlations between BDNF, proBDNF and p75 NTR levels and positive and negative symptoms scale (PANSS) scores, p75 NTR and S100B levels and suicidal parameters, as well as a correlation of BDNF plasma level with the risky decision‐making style in Iowa Gambling Task (IGT). Conclusions The results indicate a potential value of studied proteins as a biomarker in the diagnosis and monitoring of the disease's course.
26
Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders
G. Paul Amminger, Miriam R. Schäfer, Claudia M. Klier et al. · Archives of General Psychiatry · 2010 · 891 citations · Full text
Medicine, Nutrition, Psychiatry +16